{"id":"W4400901227","doi":"10.1016/s1474-4422(24)00216-3","title":"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Calgary; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Amyotrophic lateral sclerosis; Tolerability; Pharmacokinetics; Placebo; Medicine; C9orf72; Internal medicine; Pharmacology; Adverse effect; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001791833,0.0004113031,0.001734499,0.0003567674,0.0001284555,0.00007593929,0.0003291372,0.0001696286,0.00008926076],"category_scores_gemma":[0.0002779145,0.0002522813,0.0001489304,0.000743686,0.0004523779,0.0001335888,0.0002751462,0.001200326,0.00001284457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007495087,"about_ca_system_score_gemma":0.000114128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005960686,"about_ca_topic_score_gemma":0.0004831073,"domain_scores_codex":[0.9958334,0.001004516,0.0009409227,0.0007723663,0.0005621504,0.0008866442],"domain_scores_gemma":[0.9977556,0.00110353,0.0001993766,0.0006039038,0.0001416637,0.0001959381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8366715,0.002300588,0.1189301,0.0003578005,0.0007650343,0.001216326,0.002556139,0.0006656744,0.03366708,0.00002536858,0.0001636388,0.002680683],"study_design_scores_gemma":[0.6841499,0.005513011,0.269574,0.0005773499,0.0004475367,0.0001871977,0.00008267484,0.03843158,0.0006167308,0.00005263434,0.00007302457,0.0002944039],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869462,0.0005720901,0.000008649808,0.006567497,0.0002075444,0.005355954,0.00004369691,0.000151589,0.0001467928],"genre_scores_gemma":[0.9976512,0.001130921,0.00003293527,0.0005155953,0.0002592364,0.0002694889,0.00001491738,0.00007777059,0.00004795456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1525217,"threshold_uncertainty_score":0.999993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05197087178715996,"score_gpt":0.3354768177880474,"score_spread":0.2835059460008874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}